175 related articles for article (PubMed ID: 29340865)
1. Design of a tripartite network for the prediction of drug targets.
Kunimoto R; Bajorath J
J Comput Aided Mol Des; 2018 Feb; 32(2):321-330. PubMed ID: 29340865
[TBL] [Abstract][Full Text] [Related]
2. Tripartite Network-Based Repurposing Method Using Deep Learning to Compute Similarities for Drug-Target Prediction.
Zong N; Wong RSN; Ngo V
Methods Mol Biol; 2019; 1903():317-328. PubMed ID: 30547451
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing based on drug-drug interaction.
Zhou B; Wang R; Wu P; Kong DX
Chem Biol Drug Des; 2015 Feb; 85(2):137-44. PubMed ID: 24934184
[TBL] [Abstract][Full Text] [Related]
4. Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database.
Barneh F; Jafari M; Mirzaie M
Brief Bioinform; 2016 Nov; 17(6):1070-1080. PubMed ID: 26490381
[TBL] [Abstract][Full Text] [Related]
5. A review of network-based approaches to drug repositioning.
Lotfi Shahreza M; Ghadiri N; Mousavi SR; Varshosaz J; Green JR
Brief Bioinform; 2018 Sep; 19(5):878-892. PubMed ID: 28334136
[TBL] [Abstract][Full Text] [Related]
6. Many approved drugs have bioactive analogs with different target annotations.
Hu Y; Lounkine E; Bajorath J
AAPS J; 2014 Jul; 16(4):847-59. PubMed ID: 24871342
[TBL] [Abstract][Full Text] [Related]
7. Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.
Yang CC; Zhao M
Artif Intell Med; 2019 May; 96():80-92. PubMed ID: 31164213
[TBL] [Abstract][Full Text] [Related]
8. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.
Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J
BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720
[TBL] [Abstract][Full Text] [Related]
9. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
Cichonska A; Rousu J; Aittokallio T
Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
[TBL] [Abstract][Full Text] [Related]
10. In Silico Oncology Drug Repositioning and Polypharmacology.
Cheng F
Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
[TBL] [Abstract][Full Text] [Related]
11. Prediction of off-target drug effects through data fusion.
Yera ER; Cleves AE; Jain AN
Pac Symp Biocomput; 2014; 19():160-71. PubMed ID: 24297543
[TBL] [Abstract][Full Text] [Related]
12. A bidirectional drug repositioning approach for Parkinson's disease through network-based inference.
Rakshit H; Chatterjee P; Roy D
Biochem Biophys Res Commun; 2015 Feb; 457(3):280-7. PubMed ID: 25576361
[TBL] [Abstract][Full Text] [Related]
13. Recommendation Techniques for Drug-Target Interaction Prediction and Drug Repositioning.
Alaimo S; Giugno R; Pulvirenti A
Methods Mol Biol; 2016; 1415():441-62. PubMed ID: 27115647
[TBL] [Abstract][Full Text] [Related]
14. A Computational Bipartite Graph-Based Drug Repurposing Method.
Zheng S; Ma H; Wang J; Li J
Methods Mol Biol; 2019; 1903():115-127. PubMed ID: 30547439
[TBL] [Abstract][Full Text] [Related]
15. Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing.
Lim H; Poleksic A; Yao Y; Tong H; He D; Zhuang L; Meng P; Xie L
PLoS Comput Biol; 2016 Oct; 12(10):e1005135. PubMed ID: 27716836
[TBL] [Abstract][Full Text] [Related]
16. De Novo Prediction of Drug Targets and Candidates by Chemical Similarity-Guided Network-Based Inference.
Vigil-Vásquez C; Schüller A
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077062
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing with network reinforcement.
Nam Y; Kim M; Chang HS; Shin H
BMC Bioinformatics; 2019 Jul; 20(Suppl 13):383. PubMed ID: 31337333
[TBL] [Abstract][Full Text] [Related]
18. Deep-Learning-Based Drug-Target Interaction Prediction.
Wen M; Zhang Z; Niu S; Sha H; Yang R; Yun Y; Lu H
J Proteome Res; 2017 Apr; 16(4):1401-1409. PubMed ID: 28264154
[TBL] [Abstract][Full Text] [Related]
19. The drug delivery field needs a well-diversified technology portfolio.
Park K
J Control Release; 2017 Jan; 245():177. PubMed ID: 28065323
[No Abstract] [Full Text] [Related]
20. A landscape for drug-target interactions based on network analysis.
Galan-Vasquez E; Perez-Rueda E
PLoS One; 2021; 16(3):e0247018. PubMed ID: 33730052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
